Healthcare Global Enterprises Ltd
NSE:HCG

Watchlist Manager
Healthcare Global Enterprises Ltd Logo
Healthcare Global Enterprises Ltd
NSE:HCG
Watchlist
Price: 572.55 INR 0.39% Market Closed
Market Cap: ₹85.5B

EV/IC

3.3
Current
12%
More Expensive
vs 3-y average of 2.9

Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.

EV/IC
3.3
=
Enterprise Value
₹90.1B
/
Invested Capital
₹30.1B

Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.

EV/IC
3.3
=
Enterprise Value
₹90.1B
/
Invested Capital
₹30.1B

Valuation Scenarios

Healthcare Global Enterprises Ltd is trading above its 3-year average

If EV/IC returns to its 3-Year Average (2.9), the stock would be worth ₹511.42 (11% downside from current price).

Statistics
Positive Scenarios
1/4
Maximum Downside
-31%
Maximum Upside
+75%
Average Upside
4%
Scenario EV/IC Value Implied Price Upside/Downside
Current Multiple 3.3 ₹572.55
0%
3-Year Average 2.9 ₹511.42
-11%
5-Year Average 2.7 ₹475.88
-17%
Industry Average 5.7 ₹1 002.99
+75%
Country Average 2.3 ₹397.82
-31%

Forward EV/IC
Today’s price vs future invested capital

Not enough data available to calculate forward EV/IC

Peer Comparison

All Multiples
EV/IC
P/E
All Countries
Close

Market Distribution

In line with most companies in India
Percentile
62nd
Based on 2 828 companies
62nd percentile
3.3
Low
0 — 1.3
Typical Range
1.3 — 4.2
High
4.2 —
Distribution Statistics
India
Min 0
30th Percentile 1.3
Median 2.3
70th Percentile 4.2
Max 4 185.7

Healthcare Global Enterprises Ltd
Glance View

Market Cap
85.5B INR
Industry
Health Care

HealthCare Global Enterprises Ltd. provides imaging and diagnostics services for cancer treatment. The company is headquartered in Bangalore, Karnataka. The company went IPO on 2016-03-30. The firm is involved retail sale of pharmaceuticals, medical and orthopedic goods and toilet articles. The company operates cancer care network under the HCG brand. The company operates infertility treatment clinics providing assisted reproductive services under brand Milann. The firm operates eight Milann fertility centers, which provide reproductive medicine services, including assisted reproduction, gynecological endoscopy and fertility preservation; and follow a multidisciplinary and technology-focused approach to diagnosis and treatment. Milann fertility centers also offer training programs for fertility specialists and embryologists. Under the Triesta brand, it provides clinical reference laboratory services with specialization in oncology.

HCG Intrinsic Value
412.58 INR
Overvaluation 28%
Intrinsic Value
Price ₹572.55
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett